Watch Closely for Drug Interactions with Hep C Meds

More hepatitis C patients will now be treated...due to updated guidelines and a push for fewer payer restrictions.

Most patients will get one or two of the new oral meds, daclatasvir (Daklinza)...ledipasvir/sofosbuvir (Harvoni)...simeprevir (Olysio)...sofosbuvir (Sovaldi)...ombitasvir/paritaprevir/ritonavir (Technivie)...or ombitasvir/paritaprevir/ritonavir and dasabuvir (Viekira Pak).

Expect most patients to be treated for 12, 16, or 24 weeks...often based on whether they have cirrhosis or have been treated before.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals